PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-122

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 219 Posts.
    lightbulb Created with Sketch. 81

    This is very very interesting.

    I presume this means ANP was informed sometime late last Friday. Regardless of whether they are intending to go down the CR route or go with a partnership, I would have expected that we would need go into a trading half until they can release the CR/Partnership details.

    If the response Ionade got is infact saying that ANP DOES already know - I’m at a loss as to why we’re not in a TH.

    I think someone on here has said before that Mark Diamond has been repeating the mantra of ‘non dilutive funding’ in the last 6 months - can anyone confirm this?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.